Atlas Trials

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Clinical trial NCT03724071 · TERMINATED

Trial details

NCT number
NCT03724071
Sponsor
Transgene
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colorectal NeoplasmDigestive System Neoplasm
Start date
2018-10-16
Primary completion
2023-02-23
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.